TEMAZEPAM

Product NDC
71610-625
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
temazepam
Dosage form
CAPSULE
Route
ORAL
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Application
NDA018163
Marketing category
NDA
Substance
TEMAZEPAM
Current FDA listing
Yes

Related Records

Packages

Package NDCDescriptionMarketing startMarketing endSampleStatus
71610-625-1010 CAPSULE in 1 BOTTLE (71610-625-10) 2024-06-14NoHistorical
71610-625-1515 CAPSULE in 1 BOTTLE (71610-625-15) 2021-12-10NoHistorical
71610-625-2020 CAPSULE in 1 BOTTLE (71610-625-20) 2024-06-14NoHistorical
71610-625-2828 CAPSULE in 1 BOTTLE (71610-625-28) 2024-06-14NoHistorical
71610-625-3030 CAPSULE in 1 BOTTLE (71610-625-30) 2021-12-10NoHistorical
71610-625-4545 CAPSULE in 1 BOTTLE (71610-625-45) 2021-12-10NoHistorical
71610-625-5360 CAPSULE in 1 BOTTLE (71610-625-53) 2021-12-10NoHistorical
71610-625-6090 CAPSULE in 1 BOTTLE (71610-625-60) 2021-12-10NoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
Temazepam Capsules USP CIV Rx onlyAphena Pharma Solutions - Tennessee, LLC2024-06-18HUMAN PRESCRIPTION DRUG LABEL4